(124)I-iodopyridopyrimidinone for PET of Abl kinase-expressing tumors in vivo.
about
Recent Advances in the Development and Application of Radiolabeled Kinase Inhibitors for PET ImagingC2c: turning cancer into chronic diseaseEffect of small-molecule modification on single-cell pharmacokinetics of PARP inhibitorsSingle-cell and subcellular pharmacokinetic imaging allows insight into drug action in vivo.Radioiodinated Small Molecule Tyrosine Kinase Inhibitor for HER2 Selective SPECT Imaging.
P2860
(124)I-iodopyridopyrimidinone for PET of Abl kinase-expressing tumors in vivo.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
(124)I-iodopyridopyrimidinone for PET of Abl kinase-expressing tumors in vivo.
@ast
(124)I-iodopyridopyrimidinone for PET of Abl kinase-expressing tumors in vivo.
@en
type
label
(124)I-iodopyridopyrimidinone for PET of Abl kinase-expressing tumors in vivo.
@ast
(124)I-iodopyridopyrimidinone for PET of Abl kinase-expressing tumors in vivo.
@en
prefLabel
(124)I-iodopyridopyrimidinone for PET of Abl kinase-expressing tumors in vivo.
@ast
(124)I-iodopyridopyrimidinone for PET of Abl kinase-expressing tumors in vivo.
@en
P2093
P2860
P1476
(124)I-iodopyridopyrimidinone for PET of Abl kinase-expressing tumors in vivo
@en
P2093
Darren R Veach
Elmer Santos
Julius Balatoni
Juri Gelovani
Peter Smith-Jones
Steven M Larson
Tatiana Kochetkova
William Bornmann
P2860
P304
P356
10.2967/JNUMED.109.066126
P407
P577
2010-01-01T00:00:00Z